Cannabis Rescheduling: Page 7

Cannabis Rescheduling Reactions Mixed: While Some Applaud Potential, Others Push For More

Executives, lawmakers and nonprofit leaders weigh in on the significance and shortcomings of the DEA's move to reclassify cannabis as a less dangerous substance.

UPDATE: DEA Moves to Reschedule Cannabis

The federal agency that has long enforced prohibition aligns with the recommendation from the U.S. Department of Health and Human Services, FDA to reclassify cannabis as a Schedule III substance under the Controlled Substances Act.

Cannabis Rescheduling Update: Is a ‘Notoriously Secretive Agency’ Now Involved?

A report that HHS requested an opinion from the Department of Justices’ Office of Legal Counsel raises new questions and concerns. Attorney Shane Pennington explains why that request and the outcome would be crucial to the schedule review process and the industry’s future.

21 US Lawmakers Express Frustration With DEA’s Inaction on Cannabis Rescheduling

The 11 senators and 10 House representatives urged for swift action to remove cannabis from a Schedule I listing in a new letter.

The State of Federal Cannabis Reform Leads CBT’s Most-Read Articles in April

4/20 deals and events, California tax defaults, and nationwide municipal opt outs also highlighted Cannabis Business Times’ most popular stories this month.

Federal Cannabis Legalization and Reform: Where Are We in 2024?

U.S. cannabis reform hasn’t come easy amid a divided Congress, but plenty of opportunities remain on the table for the remainder of the year.

3 GOP Senators Tell DEA Not to Reschedule Cannabis

Led by former presidential candidate Mitt Romney, the senators argue rescheduling would violate an international treaty in letter to DEA administrator.

Biden’s Failed Actions on Cannabis Issues ‘Borders on Political Malpractice,’ Lawmaker Says

Rep. Earl Blumenauer asked Health Secretary Xavier Becerra to relay his concerns on cannabis reform to the president during a committee hearing.

Is Cannabis in Schedule I or V? HHS Secretary Forgets

U.S. Health Secretary Xavier Becerra couldn’t remember the plant’s classification during a subcommittee hearing on his department’s budget request, during which a dispute over HHS’ rescheduling recommendation arose.

DEA’s 5-Factor Test Makes Rescheduling Cannabis Impossible

After HHS used its own two-part test to determine the plant’s ‘currently accepted medical use,’ rescheduling opponents urge DEA to keep its five-part test.

VP Harris Urges DEA to Act 'as Quickly as Possible' on Cannabis Rescheduling Review

Harris stressed the need for a ‘resolution’ to the review of cannabis’s Schedule I classification, which she said is ‘absurd and patently unfair,’ in her opening remarks during a White House roundtable discussion to address ‘inequities in federal drug policy.’

36 US House Democrats Urge Biden to Grant Cannabis Clemency For Thousands

Congressional Cannabis Caucus co-chairs Barbara Lee and Earl Blumenauer spearheaded a letter asking for those currently incarcerated to be released.

Previous Page

Page 7 of 12

Next Page